Start Codon announces first cohort of companies

Start Codon announces first cohort of companies

Start Codon, the new healthcare accelerator based in the Milner Therapeutics Institute, today announced the first cohort of four companies who were enrolled in the programme this February and will debut at the Milner Symposium event this Friday June 26th and ONHelix...
Eisai join Milner Therapeutics Consortium

Eisai join Milner Therapeutics Consortium

We are delighted to announce that Eisai have joined the Milner Therapeutics Consortium, which now includes 8 pharma partners. Eisai is a leading global research and development-based pharmaceutical company headquartered in Japan. Eisai’s corporate mission is defined...

Milner Institute illuminated blue for the NHS

The Jeffrey Cheah Biomedical Centre illuminated blue tonight, to honour the incredible work of our NHS. Milner Institute Director Professor Tony Kouzarides said “On behalf of scientists in Cambridge and throughout the UK, we thank NHS staff for their selfless...
Milner seminars move online

Milner seminars move online

We have been busy adapting plans for the coming months, and are pleased to announce that our Milner seminars are moving online. The first talk is from Mathew Garnett, and we hope you will join us online for this!  Dr Mathew Garnett (Wellcome Sanger Institute)...
Providing COVID-19 support

Providing COVID-19 support

Thank you to the numerous Milner affiliated companies who have been in contact to offer support  to the University and NHS at this time. Help tackle COVID-19 through research collaborations, by donating equipment or funding research The University of Cambridge is...
Providing COVID-19 support

Milner Institute closure for COVID-19

As part of the response to COVID-19 at the University of Cambridge, the Milner Therapeutics Institute will be closed for non-essential business from Friday March 20th until further notice. Events planned for March and April, including the Milner seminar series, have...

Pin It on Pinterest